Hepatitis C Warning || WXYZ.com | WXYZ-TV / Detroit | Detroit News, Weather, Sports and More

"Hepatitis C is a serious illness. It often has no symptoms and unlike other forms of hepatitis, it has no vaccine.
But one thing it does have is an advocate who is working tirelessly to spread the word about diagnosis and treatment.

Christopher Kennedy Lawford is an actor, an author and an advocate. He has spent time in Hollywood and in Hyannisport. But now he’s traveling across the country to talk about a disease he fears will soon become a health care crisis."

Hepatitis C blood victims get compensation snub - mirror.co.uk

"Thousands of haemophiliacs infected with hepatitis C by the NHS were yesterday refused extra compensation.

Some 4,670 were given contaminated blood in the 1970s and 1980s. More than 1,240 of these also got HIV.

An independent inquiry earlier this year recommended payouts of £750,000 for hepatitis C victims and £88,668 for those with HIV."

WHKP 1450 AM Radio Henderson County - Research Says Hepatitis B Vaccine May Reduce Risk of Liver Cancer

"There is strong data that shows that the Hepatitis B vaccine reduces the risk of liver cancer according to local Oncologist Dr. William Medina. He told WHKP News that anyone over the age of 18 can take this vaccine. He also talked about the beneifts for health care workers, and certain ethnic groups such as Asian Americans who are at high risk of contracting Hepatitis B."

Study: New antibody helps protect against hepatitis C infection - Related Stories - AABB SmartBrief

"In a U.S. study, a human monoclonal antibody called MBL-HCV1 weakened the hepatitis C virus and prevented it from infecting an animal disease model. The finding may lead to a new treatment for hepatitis C, but further studies are needed to determine the efficacy of the antibody in humans, a researcher said."

New Delhi rejects American firm's plea to patent Hepatitis B drug- Pharmaceuticals-Healthcare / Biotech-News By Industry-News-The Economic Times

"The Delhi Patent Office has rejected American company Gilead Sciences’ plea to patent its Hepatitis B drug adefovir dipivoxil sold
under the brand name Hepsera. India’s largest drugmaker Ranbaxy had filed a pre-grant opposition against Gilead’s patent application saying that it is not a new drug and lacked inventions."